Sensex falls! These stocks are down 5% or more on BSE
Sensex rises! But these stocks fell 5% or more in Tuesday's session
Sensex rises! But these stocks fell 5% or more in Tuesday's sessionNo Data Available
Chandra Bhagat Pharma Share Price
BSE
Loading...
| Open | - |
| High | - |
| Low | - |
| Prev Close | - |
| Volume | - |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | - |
| EPS - TTM(₹) | - |
| MCap(₹ Cr.) | 32.22 |
| MCap Rank | 179 |
| PB Ratio(x) | 1.02 |
| Div Yield(%) | - |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 59.00 |
| 52W Low(₹) | 29.70 |
| MCap/Sales | 0.20 |
| Beta(1 Month) | - |
| BV/Share(₹) | 43.90 |
Chandra Bhagat Pharm share price insights
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 29.74% outperformed its 3 year CAGR of -0.09%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 1.72% of its operating revenues towards interest expenses and 2.59% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Chandra Bhagat Pharm Share Price Update
Chandra Bhagat Pharma Ltd. share price moved down by -4.68% from its previous close of Rs 44.80. Chandra Bhagat Pharma Ltd. stock last traded price is 42.70
Share Price Value Today/Current/Last 42.70 Previous Day 44.80
Found Insights useful?
Chandra Bhagat Pharm Share Price Returns
| 1 Day | -4.68% |
| 1 Month | N.A. |
| 3 Months | N.A. |
| 1 Year | N.A. |
| 3 Years | -67.15% |
| 5 Years | -28.83% |
Chandra Bhagat Pharm Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
Financials
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Revenue 119.63 92.20 232.70 119.97 95.70 Total Revenue Growth (%) 29.74 -60.38 93.98 25.36 34.46 Total Expenses 115.52 91.04 230.44 118.80 94.60 Total Expenses Growth (%) 26.89 -60.49 93.97 25.59 33.44 Profit after Tax (PAT) 3.05 0.86 1.53 0.91 0.80 PAT Growth (%) 255.12 -43.95 69.02 13.64 319.58 Operating Profit Margin (%) 5.25 3.58 1.64 2.79 4.43 Net Profit Margin (%) 2.61 0.98 0.69 0.75 0.84 Basic EPS (₹) 4.04 1.14 2.03 1.20 1.06 InsightsBeating 3 Yr Revenue CAGR
Company's annual revenue growth of 29.74% outperformed its 3 year CAGR of -0.09%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 1.72% of its operating revenues towards interest expenses and 2.59% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 94.21 101.53 101.80 60.58 72.46 Total Assets Growth (%) -7.21 -0.27 68.04 -16.40 0.95 Total Liabilities 61.08 71.56 72.80 33.10 45.79 Total Liabilities Growth (%) -14.65 -1.70 119.94 -27.71 -0.24 Total Equity 33.13 29.97 29.01 27.48 26.68 Total Equity Growth (%) 10.54 3.31 5.57 3.00 3.09 Current Ratio (x) 1.50 1.41 1.38 2.19 1.86 Total Debt to Equity (x) 0.50 0.70 0.57 0.69 0.74 Contingent Liabilities 0.00 - - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities 9.24 -5.58 6.18 5.26 12.46 Net Cash used in Investing Activities -0.43 -1.23 -1.85 -0.06 0.09 Net Cash flow from Financing Activities -6.36 2.19 -5.80 -4.45 -9.62 Net Cash Flow 2.45 -4.62 -1.48 0.76 2.92 Closing Cash & Cash Equivalent 3.11 0.34 4.96 6.44 5.75 Closing Cash & Cash Equivalent Growth (%) 809.27 -93.11 -22.91 12.08 137.33 Total Debt/ CFO (x) 1.79 -3.74 2.66 3.60 1.59 All figures in Rs Cr, unless mentioned otherwise
InsightsDecrease in Cash from Investing
Company has used Rs 0.43 cr for investing activities which is an YoY decrease of 64.73%. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) 9.19 2.86 5.27 3.29 2.98 Return on Capital Employed (%) 17.09 9.64 11.86 9.95 12.12 Return on Assets (%) 3.23 0.84 1.50 1.49 1.09 Interest Coverage Ratio (x) 3.60 2.09 3.09 1.65 1.40 Asset Turnover Ratio (x) 1.19 0.85 2.73 1.80 1.30 Price to Earnings (x) 7.56 46.08 46.95 81.30 108.70 Price to Book (x) 0.69 1.32 2.47 2.66 3.22 EV/EBITDA (x) 5.05 14.68 19.38 23.71 23.26 EBITDA Margin (%) 6.19 4.68 1.93 3.01 4.56
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
Mutual Funds Ownership
No Data Available
Chandra Bhagat Pharm Top Searches
Corporate Actions
Board Meeting
Audited Results
May 19, 2026
Board Meeting
Half Yearly Results
Nov 07, 2025
General Meeting
-
Sep 16, 2025
Announced on Meeting on May 19, 2026 May 25, 2026 Audited Results Nov 07, 2025 Nov 13, 2025 Half Yearly Results May 26, 2025 May 29, 2025 Audited Results Nov 07, 2024 Nov 13, 2024 Half Yearly Results May 23, 2024 May 30, 2024 Audited Results No Data Available
No Data Available
No Data Available
No Data Available
Announced on Meeting on Sep 16, 2025 Sep 30, 2025 - Sep 10, 2024 Sep 30, 2024 A.G.M. Sep 06, 2023 Sep 30, 2023 A.G.M. Dec 01, 2020 - Book closure from Dec 17, 2020 to Dec 23, 2020 Dec 01, 2020 Dec 23, 2020 Book closure from Dec 17, 2020 to Dec 23, 2020
About Chandra Bhagat Pharm
Industry
Key Indices Listed On
-
Address
323-F Bhagat Bhuvan,Dr. Ambedkar Road,Matunga (East),Mumbai, Maharashtra - 400019
Executive Leadership
HC
Hemant Chandravadan Bhagat
Chairman & Managing DirectorPP
Prachi Pranav Bhagat
Director & CFOPH
Pranav Hemant Bhagat
Whole Time DirectorAP
Abha Praveen Doshi
Independent DirectorShow More
Auditors
A Y & Co.
FAQs about Chandra Bhagat Pharm share
- 1. What is Chandra Bhagat Pharm share price and what are the returns for Chandra Bhagat Pharm share?Chandra Bhagat Pharm share price is Rs 42.70 as on 03 Jul, 2026, 03:40 PM IST. Chandra Bhagat Pharm share price is down by 4.68% based on previous share price of Rs. 44.01.
- 2. What's the market capitalization of Chandra Bhagat Pharm?Market Capitalization of Chandra Bhagat Pharm stock is Rs 32.22 Cr.
- 3. What is 52 week high/low of Chandra Bhagat Pharm share price?In last 52 weeks Chandra Bhagat Pharm share had a high price of Rs 59.00 and low price of Rs 29.70
- 4. What are the returns for Chandra Bhagat Pharm share?Return Performance of Chandra Bhagat Pharm Shares:
- 1 Week: Chandra Bhagat Pharm share price moved remain unchanged by N.A.
- 5. What is the PE & PB ratio of Chandra Bhagat Pharm?The PE ratio of Chandra Bhagat Pharm stands at null, while the PB ratio is 1.02.
Top Gainers
As on 04:10 PM | 03 Jul 2026Top Losers
As on 04:10 PM | 03 Jul 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.